Hannah Koepsell was 11 years old when she was diagnosed with acute lymphoblastic leukemia (ALL), a cancer of the blood and bone marrow. Two years of chemotherapy followed, and in 2024, she rang the ...
Progression-free survival reached 14.3 months with Enhertu versus 8.3 months with chemotherapy plus Keytruda in HER2-mutant ...
For Wyman, that perspective has become part of what comes after his daughter's cancer journey. Emma is now a healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results